Lahore: Citi Pharma Limited has announced that its Board of Directors will convene on April 30, 2025, in Lahore to review the company's quarterly accounts for the period ending March 31, 2025. The meeting will also consider the declaration of any entitlement for its shareholders.

In compliance with the Pakistan Stock Exchange (PSX) regulations, Citi Pharma Limited has implemented a closed period from April 23, 2025, to April 30, 2025. During this timeframe, no director, chief executive officer, or executive of the company is permitted to engage in any transaction involving the company's shares, either directly or indirectly.

According to information available from the Pakistan Stock Exchange (PSX), this closed period is a standard practice to ensure fair trading and uphold market integrity. The company has communicated this information to the TRE Certificate Holders of the Exchange.

Citi Pharma Limited operates within the pharmaceutical sector, and the upcoming board meeting is part of its routine financial review process. The company's compliance with the PSX regulations reflects its commitment to transparency and adherence to market rules.